Vergent Bioscience Company
.jpg)
Vergent Bioscience is a biotech company leading the development of tumor-targeted molecular imaging molecules for cancer surgery.
Total Funding:
$12 916 407
Headquarters:
Minneapolis, Minnesota, United States
Estimated Revenue:
Less than $1M
Last Funding Type:
Venture - Series Unknown
Last Funding Date:
2019-02-22
Founded Date:
2016-01-01
Industry:
Women Cancer Treatment